and so there are monoclonals and there are monoclonals, and we have to be mindful of that, as well. some of the monoclonals, most of them are directed against the spike protein and the omicron spike protein has so many mutations in it that some of the monoclonals won t work. we may even have to revisit convalescent antibody again and see if that offers any benefits. and the mayor is right, we need to accelerate that pfizer drug. that s going to be really imperative. and here s the other piece that i think not enough of us are talking about. which is, this is really a one, two, three punch epidemic right now. because we ve got delta still. delta is still in play. omicron s accelerating, but the third piece is we re seeing a lot of breakthrough infections among hospital workers, among health care providers. not even some who have gotten the third immunization, not that they re getting very sick enough to go to the hospital, but enough to knock them out of the health care workforce.
Wie lange der Schutz nach einer Covid-Infektion hält: Offenbar länger immun als vermutet - Wissen
tagesspiegel.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tagesspiegel.de Daily Mail and Mail on Sunday newspapers.
Corona und 2G-Regeln: Sind Genesene nur sechs Monate geschützt?
sueddeutsche.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sueddeutsche.de Daily Mail and Mail on Sunday newspapers.
Sind Corona-Genesene wirklich nur sechs Monate geschützt?
otz.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from otz.de Daily Mail and Mail on Sunday newspapers.
Infektion statt Imfpung: Sind Corona-Genesene wirklich nur sechs Monate geschützt?
aachener-nachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aachener-nachrichten.de Daily Mail and Mail on Sunday newspapers.